(131)I-apamistamab effectively achieved durable responses in patients with R/R AML irrespective of the presence of multiple high-risk factors Meeting Abstract
| Authors: | Seropian, S.; Foran, J. M.; Gyurkocza, B.; Nath, R.; Choe, H.; Litzow, M. R.; Koshy, N.; Stiff, P. J.; Tomlinson, B. K.; Abhyankar, S.; Abedin, S.; Chen, G.; Al-Kadhimi, Z.; Kebriaei, P.; Sabloff, M.; Orozco, J. J.; Jamieson, K. J.; Magalhaes-Silverman, M.; Van Besien, K.; Schuster, M. W.; Law, A. D.; Mayer, S. A.; Lazarus, H. M.; Spross, J.; Li, K. L.; Haeuber, E.; Vusirikala, M.; Nahar, A.; Sandmaier, B. M.; Pagel, J.; Giralt, S. A.; Desai, A.; Abboud, C. N. |
| Abstract Title: | (131)I-apamistamab effectively achieved durable responses in patients with R/R AML irrespective of the presence of multiple high-risk factors |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 2159 |
| Language: | English |
| ACCESSION: | WOS:001159306708132 |
| DOI: | 10.1182/blood-2023-187433 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work